AP9801234A0 - Cox-2 selective carprofenor treating pain and inflammation in dogs. - Google Patents

Cox-2 selective carprofenor treating pain and inflammation in dogs.

Info

Publication number
AP9801234A0
AP9801234A0 APAP/P/1998/001234A AP9801234A AP9801234A0 AP 9801234 A0 AP9801234 A0 AP 9801234A0 AP 9801234 A AP9801234 A AP 9801234A AP 9801234 A0 AP9801234 A0 AP 9801234A0
Authority
AP
ARIPO
Prior art keywords
cox
acids
activity
dogs
inhibition
Prior art date
Application number
APAP/P/1998/001234A
Other languages
English (en)
Inventor
Kristin Marie Lundy
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP9801234A0 publication Critical patent/AP9801234A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
APAP/P/1998/001234A 1997-05-05 1998-05-04 Cox-2 selective carprofenor treating pain and inflammation in dogs. AP9801234A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
AP9801234A0 true AP9801234A0 (en) 1999-11-04

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001234A AP9801234A0 (en) 1997-05-05 1998-05-04 Cox-2 selective carprofenor treating pain and inflammation in dogs.

Country Status (32)

Country Link
EP (1) EP0988034A1 (fr)
JP (1) JP2000513020A (fr)
KR (2) KR20040004406A (fr)
CN (1) CN1255059A (fr)
AP (1) AP9801234A0 (fr)
AR (2) AR011726A1 (fr)
AU (1) AU6932198A (fr)
BG (1) BG103852A (fr)
BR (1) BR9808720A (fr)
CA (1) CA2288759A1 (fr)
DZ (1) DZ2479A1 (fr)
EA (1) EA003696B1 (fr)
GT (1) GT199800063A (fr)
HR (1) HRP980244A2 (fr)
HU (1) HUP0001286A3 (fr)
ID (1) ID21311A (fr)
IL (1) IL132570A0 (fr)
IS (1) IS5220A (fr)
MA (1) MA26491A1 (fr)
NO (1) NO995389L (fr)
NZ (1) NZ500183A (fr)
OA (1) OA11213A (fr)
PA (1) PA8450601A1 (fr)
PE (1) PE72599A1 (fr)
PL (1) PL337003A1 (fr)
SK (1) SK148199A3 (fr)
TN (1) TNSN98059A1 (fr)
TW (1) TW590773B (fr)
UY (1) UY24989A1 (fr)
WO (1) WO1998050033A1 (fr)
YU (1) YU55899A (fr)
ZA (1) ZA983722B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
CA2347365A1 (fr) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Produit de combinaison comprenant un ligand de prostaglandine de type e et un inhibiteur selectif de cox-2, et procedes d'utilisation dudit produit
EP1637137A3 (fr) * 1999-03-10 2006-07-05 G.D. Searle LLC Méthode et composition se rapportant à l'administration d'un inhibiteure de la cyclooxygénase-2 aux animaux
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2004521856A (ja) * 2000-05-15 2004-07-22 メルク フロスト カナダ アンド カンパニー Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物
AU6837701A (en) 2000-06-13 2001-12-24 American Home Prod Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
US20020106707A1 (en) 2000-08-07 2002-08-08 Marnett Lawrence J. Compositions and methods for detecting and quantifying COX-2 activity and anandamide metabolites
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
PT1534305E (pt) 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
WO2005009436A1 (fr) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Formulation dispersable d'un agent anti-inflammatoire
EP1940380A2 (fr) * 2005-05-20 2008-07-09 Pfizer Limited Combinaisons synergiques des medicaments anti-inflammatoires non steroidiens avec des ligands alpha-2 delta
US8535713B2 (en) 2007-04-04 2013-09-17 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
US8951570B2 (en) 2007-04-26 2015-02-10 Sigmoid Pharma Limited Manufacture of multiple minicapsules
JP5640079B2 (ja) 2009-05-18 2014-12-10 シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ 油滴含有組成物
BR112012002963A2 (pt) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CA2941008C (fr) 2014-03-06 2022-07-26 Aratana Therapeutics, Inc. Compositions de grapiprant et ses procedes d'utilisation
EP3215127B1 (fr) 2014-11-07 2020-10-28 Sublimity Therapeutics Limited Compositions comprenant de la cyclosporine
BR112017014750A2 (pt) * 2015-01-09 2018-06-19 Jaguar Animal Health métodos para tratamento de diarreia em animais de estimação
CN115335046A (zh) * 2020-03-25 2022-11-11 思研（Sri）国际顾问与咨询公司 脂肪氧合酶抑制剂
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes

Also Published As

Publication number Publication date
WO1998050033A1 (fr) 1998-11-12
HUP0001286A3 (en) 2000-12-28
HUP0001286A2 (hu) 2000-11-28
KR20010012300A (ko) 2001-02-15
DZ2479A1 (fr) 2003-02-01
PA8450601A1 (es) 2000-05-24
MA26491A1 (fr) 2004-12-20
JP2000513020A (ja) 2000-10-03
EA003696B1 (ru) 2003-08-28
BR9808720A (pt) 2000-07-11
EP0988034A1 (fr) 2000-03-29
HRP980244A2 (en) 1999-02-28
TNSN98059A1 (fr) 2005-03-15
PE72599A1 (es) 1999-08-12
SK148199A3 (en) 2001-09-11
BG103852A (en) 2000-06-30
CN1255059A (zh) 2000-05-31
AU6932198A (en) 1998-11-27
AR011726A1 (es) 2000-08-30
ZA983722B (en) 1999-11-04
ID21311A (id) 1999-05-20
PL337003A1 (en) 2000-07-31
GT199800063A (es) 1999-10-26
NO995389L (no) 2000-01-04
NZ500183A (en) 2002-04-26
OA11213A (en) 2003-07-14
EA199900895A1 (ru) 2000-06-26
NO995389D0 (no) 1999-11-04
CA2288759A1 (fr) 1998-11-12
IS5220A (is) 1999-10-19
AR039628A2 (es) 2005-03-02
YU55899A (sh) 2003-08-29
KR20040004406A (ko) 2004-01-13
TW590773B (en) 2004-06-11
UY24989A1 (es) 2001-10-25
IL132570A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
AP9801234A0 (en) Cox-2 selective carprofenor treating pain and inflammation in dogs.
NZ330860A (en) Method of inhibiting photoaging of skin
HK1034189A1 (en) An acidified composition for topical treatment of nail and skin conditions.
WO1999046279A3 (fr) INHIBITEURS DE LA 17β-HYDROXYSTEROIDE DESHYDROGENASE DU TYPE 5 ET DU TYPE 3 ET METHODES D'UTILISATION ASSOCIEES
EE04416B1 (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
EA200000825A1 (ru) Композиция, включающая ингибитор il-1 и полимер, контролирующий высвобождение
WO2000028980A3 (fr) Methode de traitement de la douleur
CA2379649A1 (fr) Inhibition selective de la cyclo-oxygenase 2
DE50014190D1 (de) Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
NO985575L (no) FremgangsmÕter og preparater anvendelige for inhibering av <alfa>v<beta>5-mediert angiogenese
NO20002440D0 (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
BR0011172A (pt) Derivados do 4,5-diaril-3(2h)-furanona como inibidores de cliclooxigenase-2
AU3346095A (en) Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system
IL143594A0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
AU6330799A (en) Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
WO1998018440A3 (fr) Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles
DE69518073T2 (de) Pyrazol-Carbonsäurederivate als Mittel zur Bekämpfung von Pflanzenkrankheiten
AU1214900A (en) Irrigation solution and method for inhibition of pain and inflammation
CO5021216A1 (es) Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros
HUP0001097A2 (hu) COMT-inhibitorok alkalmazása cukorbetegséggel kapcsolatos érrendszeri rendellenességek megelőzésére alkalmas gyógyszerkészítmények előállítására
NO20001812L (no) Gallesyresalter av metaller med fysiologisk virkning, samt terapeutisk anvendelse derav
BR0213634A (pt) Sistema de liberação de droga com ação retardada para um agente antiespasmódico
ATE286892T1 (de) Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität
FR2760363B1 (fr) Composition pour le traitement topique des affections de la peau et des phaneres
AU1214800A (en) Irrigation solution and method for inhibition of pain and inflammation